Table 1 From Phase I And Pharmacokinetic Study Of Flavopiridol Followed

Table 1 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 1 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 2 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 2 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 3 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 3 from Phase I and Pharmacokinetic Study of Flavopiridol followed ...
Table 1 from Phase 1 and pharmacokinetic study of bolus-infusion ...
Table 1 from Phase 1 and pharmacokinetic study of bolus-infusion ...
Table 1 from Phase 1 and pharmacokinetic study of bolus-infusion ...
Table 1 from Phase 1 and pharmacokinetic study of bolus-infusion ...
(PDF) Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol ...
(PDF) Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol ...
Table 1 from Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569 ...
Table 1 from Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569 ...
Table 2 from Phase I safety, pharmacokinetic and pharmacodynamic study ...
Table 2 from Phase I safety, pharmacokinetic and pharmacodynamic study ...
Table 1 from Clinical Study A Phase II Study of Flavopiridol in ...
Table 1 from Clinical Study A Phase II Study of Flavopiridol in ...
A phase I clinical and pharmacokinetic study of weekly docetaxel ...
A phase I clinical and pharmacokinetic study of weekly docetaxel ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Phase I clinical and pharmacokinetic study of a novel schedule of ...
Table 1 from Pharmacokinetic Study of Bioactive Flavonoids in the ...
Table 1 from Pharmacokinetic Study of Bioactive Flavonoids in the ...
(PDF) Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil ...
(PDF) Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil ...
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive ...
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive ...
Table 1 from Comparative pharmacokinetic study on phenolic acids and ...
Table 1 from Comparative pharmacokinetic study on phenolic acids and ...
Figure 1 from A phase 1 randomized study of hemodynamic effects and ...
Figure 1 from A phase 1 randomized study of hemodynamic effects and ...
Phase I trial of the combination of flavopiridol and imatinib mesylate ...
Phase I trial of the combination of flavopiridol and imatinib mesylate ...
Phase I Trial of the Combination of Flavopiridol and Imatinib Mesylate ...
Phase I Trial of the Combination of Flavopiridol and Imatinib Mesylate ...
Table 1 from The correlation of plasma proteins binding capacity and ...
Table 1 from The correlation of plasma proteins binding capacity and ...
(PDF) Phase I Trial of the Combination of Flavopiridol and Imatinib ...
(PDF) Phase I Trial of the Combination of Flavopiridol and Imatinib ...
Table 1 from Guidelines for pharmacokinetic and pharmacodynamic studies ...
Table 1 from Guidelines for pharmacokinetic and pharmacodynamic studies ...
Figure 1 from Sequential combination of flavopiridol and docetaxel ...
Figure 1 from Sequential combination of flavopiridol and docetaxel ...
Phase I study in healthy male subjects: summary of pharmacokinetic ...
Phase I study in healthy male subjects: summary of pharmacokinetic ...
A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and ...
A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and ...
Table 1 from A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis ...
Table 1 from A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis ...
Table 1 from A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis ...
Table 1 from A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis ...
Pharmacokinetic parameters of flavopiridol and its derivatives obtained ...
Pharmacokinetic parameters of flavopiridol and its derivatives obtained ...
Table 1 from The Pharmacological Implications of Flavopiridol: An ...
Table 1 from The Pharmacological Implications of Flavopiridol: An ...
A phase 1 clinical trial of flavopiridol consolidation in chronic ...
A phase 1 clinical trial of flavopiridol consolidation in chronic ...
(PDF) A dose-finding, pharmacokinetic and pharmacodynamic study of a ...
(PDF) A dose-finding, pharmacokinetic and pharmacodynamic study of a ...
A dose-finding, pharmacokinetic and pharmacodynamic study of a novel ...
A dose-finding, pharmacokinetic and pharmacodynamic study of a novel ...
Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in ...
Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in ...
(PDF) Phase 1 Trial of Flavopiridol Combined with Cisplatin or ...
(PDF) Phase 1 Trial of Flavopiridol Combined with Cisplatin or ...
(PDF) Phase 1 Trial of Flavopiridol Combined with Cisplatin or ...
(PDF) Phase 1 Trial of Flavopiridol Combined with Cisplatin or ...

Loading image details...

Source
Dimensions